SMOX Inhibition Preserved Visual Acuity and Retinal Function in Diabetic Mice
Author Information
Author(s): Alfarhan Moaddey, Liu Fang, Matani Bayan R., Somanath Payaningal R., Narayanan S. Priya, Ghiam Mehrnoosh Saghizadeh, Coulson-Thomas Vivien
Primary Institution: University of Georgia
Hypothesis
Does SMOX inhibition improve visual acuity and reduce neuro-glial injury in diabetic mice?
Conclusion
SMOX inhibition improved visual acuity, contrast sensitivity, and retinal function while reducing neuro-glial damage in diabetic mice.
Supporting Evidence
- MDL 72527 treatment improved visual acuity and contrast sensitivity in diabetic mice.
- Diabetes-induced changes in retinal function were mitigated by SMOX inhibition.
- Significant reductions in neuro-glial injury were observed with SMOX inhibition.
- Electroretinography showed improved responses in treated diabetic mice.
- Retinal markers for neuronal health improved with MDL 72527 treatment.
Takeaway
This study found that a special treatment helped mice with diabetes see better and reduced damage in their eyes.
Methodology
The study used a diabetic mouse model treated with MDL 72527 to assess visual acuity, contrast sensitivity, and retinal function over 24 weeks.
Limitations
The study only used a type 1 diabetes model and did not explore other therapeutic approaches beyond pharmacological inhibition.
Participant Demographics
8- to 10-week-old male C57BL6 mice
Statistical Information
P-Value
p<0.01
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website